| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |